Viewing Study NCT02720120


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2025-12-26 @ 3:05 AM
Study NCT ID: NCT02720120
Status: TERMINATED
Last Update Posted: 2016-03-28
First Post: 2016-03-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module